One goal of vaccination is to promote development of mucosal effector cells that can immediately respond to peripheral infection. This is especially important for protection against viruses that enter the host through the respiratory tract. We show that targeting the OX40 costimulatory receptor (CD134) strongly promotes mucosal memory in the CD8 T cell compartment. Systemic injection of an agonist antibody to OX40 strongly enhanced development of polyfunctional effector CD8 T cells that were induced after intraperitoneal infection with a highly virulent strain of vaccinia virus. These cells located to both lymphoid organs and also the lung, and importantly long-term memory CD8 T cells were maintained in the lung over one year. Anti-OX40 also boosted memory development when mice were vaccinated subcutaneously with viral peptide. These CD8 T cells were sufficient to provide protection from lethal respiratory infection with live vaccinia virus independent of CD4 T cells and antibody. Again the CD8 T cell populations that were induced after secondary infection displayed polyfunctionality, and were maintained in the lung for over a year. These data suggest that agonists to the OX40 costimulatory receptor represent potential candidates for incorporation into vaccines for respiratory viruses.
Introduction

Results
Anti-OX40 Treatment Enhances Generation of Virus-Specific CD8 T cells in
Response to Virulent VACV-WR
To assess the potential of targeting OX40 to promote protective tissue resident virus-specific memory CD8 T cell populations, we focused on systemic priming so this should not provide a bias to generating mucosa-associated T cells. Additionally, many vectors that are being used as vaccine vehicles are being tested systemically because of possible safety concerns regarding mucosal immunization, as well as simple logistical issues associated with the efficiency of mucosal as opposed to systemic vaccination. We previously showed that an agonist antibody to OX40 enhanced the generation of effector CD8 T cells when given following infection with an attenuated vaccinia virus strain (VACV-Lister) that normally elicits a weak CD8 T cell response that does not involve endogenous OX40/OX40L interactions (42). We then focused on a non-attenuated strain, VACV-Western Reserve, that elicits much stronger CD8 T cell priming when dominant and subdominant epitope-specific populations are taken into account. Although endogenous OX40 interactions are required for generating high frequencies of effector CD8 T cells to VACV-WR (42, 43) the agonist antibody strongly promoted many more functional effector cells making IFN-γ in the spleen after 1 week. This applied to both the immunodominant population reactive with the epitope B8R, as well as less dominant populations, such that each were boosted in number by a minimum of 3-fold ( Fig. 1A-C) .
Thus, even with a strongly replicating virus that normally results in engagement of on July 12, 2017 by guest http://jvi.asm.org/ Downloaded from OX40/OX40L to drive CD8 T cell priming, supplementing endogenous OX40 signals can still further enhance the generation of effector T cells.
Next co-staining for intracellular IFN-γ and TNF was performed on B8R-specific effector CD8 T cells to determine if there were entirely different populations of virusspecific T cells or if there were subsets within the IFN-γ-producing population. In general, the majority of B8R-specific CD8 T cells produced IFN-γ with a minor population that produced TNF only (Fig. 1B) . The B8R-specific CD8 T cells that produced IFN-γ could be divided into three subsets based on the TNF cytokine pattern: IFN-γ + only (single producers; gate C), IFN-γ + TNF-medium (double producers; gate B), and IFN-γ + TNF + -high (double producers; gate A). Anti-OX40 treatment increased the frequency of all three populations (Fig 1B; top panel) . Using MFI analysis, Precopio et al. (36) found an association between the MFI of IFN-γ and the degree of polyfunctionality in VACVspecific CD8 T cells. Specifically, cells with increasing function (ability to produce TNF, IL-2, and MIP1-α) had higher MFI of IFN-γ staining, and thus produced more cytokine per cell (36). Analysis of the MFI staining within each gated population revealed that anti-OX40 treatment increased the MFI of IFN-γ but not TNF in the population that produced the highest levels of both IFN-γ and TNF (gated population A).
Lastly, the effect of targeting OX40 on eliciting primary VACV-specific CD8 T cell populations was not dependent on CD4+ T cells as it occurred equivalently in MHC class II knockout animals ( Fig. 1D and E) . Signaling through OX40 therefore represents a strong exogenous stimulus for promoting systemic primary effector CD8 T cells regardless of whether infection is with attenuated or non-attenuated vaccinia virus.
Most significantly, we observed a strong accumulation of VACV-reactive effector CD8 T cells in the lungs after 8 days, even though the virus infection and anti-OX40 injection was in the peritoneal cavity ( Fig. 2A and B) . This substantiated the possibility that OX40 signals might promote mucosal memory, and in line with this we observed markedly enhanced numbers of virus-specific CD8 T cells 360 days after infection and anti-OX40 treatment (Fig. 2C ). This correlated with the fact that very few memory CD8
T cells were present in the lungs of VACV-infected OX40-deficient mice at this time ( Fig. 2C) . Thus, OX40 signaling is a dominant driving force in generating long-lived CD8 T cell memory that locates to the lung. VACV-specific primary effector CD8 T cells and in particular the polyfunctional subset that made high levels of TNF and IFN-γ, and this was observed not only in the spleen (Fig 3A) , but also markedly in the lungs (Fig. 3B) .
Anti-OX40 Treatment Enhances the
Anti-OX40 Treatment Combined with a Single CD8 T cell Peptide Epitope of
VACV Protects Mice Against Lethal Respiratory Challenge
To determine if targeting OX40 resulted in protective mucosal memory, immunized and anti-OX40-treated mice were infected intranasally with VACV-WR three weeks later (Fig. 4A) . Upon infection with a normally lethal dose of virus, 90% of the anti-OX40 treated mice survived with only moderate loss of body weight, whereas only 20% survived when OX40 was not targeted and loss of body weight was far more severe ( Fig. 4B and C) . Correspondingly, at the peak of the T cell response at day 5, viral titers were only reduced in mice that previously received anti-OX40 (Fig. 4D) , and the inflammatory response in the lung that is a consequence of virus persistence was dramatically reduced ( This threshold was clearly achieved in the lung over an 18-month period following anti-OX40 treatment (Fig. 5C ). Furthermore, these cells in the lung retained their polyfunctionality, being capable of making high levels of IFN-γ and TNF, whereas the long-lived population present in the lung that resulted from vaccination in the absence of anti-OX40 contained a much lower frequency capable of exhibiting this phenotype ( and 5F). In contrast, the long-lived CD8 memory populations in the control mice that
were not immunized with anti-OX40 did exhibit some CD4 T cell dependence (compare It is not clear that promoting mucosal memory is specific to OX40 stimulation, nor is it indicative of OX40 promoting a differential migratory pattern in memory cells, and this needs to be examined in the future. However, interestingly, in our previous studies of OX40-deficient mice (42, 43) and those here (Fig. 2) , the lack of endogenous OX40 signals severely restricted the VACV-specific memory CD8 T cell population that was found in the lungs. This also correlated with a study of CD4 T cells where OX40-deficient mice displayed a profound defect in the number of polyclonal memory cells found in peripheral tissues including the lung and lamina propria. Furthermore, in several immunization protocols, a severe defect was observed in generating CD4 T cell populations displaying an effector memory phenotype that is most commonly associated on July 12, 2017 by guest http://jvi.asm.org/ Downloaded from with localization to peripheral tissues (52). Similarly, it was found during CD8 T cell priming to Listeria monocytogenes that so-called memory precursor effector cell development was strongly impaired in OX40-deficient mice, resulting in very few memory T cells being generated (31). Therefore, regardless of whether OX40 signaling directly or specifically promotes T cell memory that can locate to peripheral tissues, these results together with our data here on vaccinia virus-specific memory CD8 T cell populations suggest that targeting OX40 in vaccines may be highly desirable to promote protective memory to poxviruses and likely other viruses that may enter the body through mucosal tissues. 
